China Donates Sinopharm COVID-19 Vaccines to Sudan

Sudan will receive its first shipment of 250,000 doses of the Chinese Sinopharm COVID-19 vaccine on Friday, 26 March 2021, the Chinese Ambassador to Sudan Ma Xinmin and Sudan News Agency (SUNA) announced on Wednesday, 24 March 2021.

‘The Chinese government and military have decided to donate a batch of COVID-19 vaccines to Sudan,’ said Ambassador Ma made at a press conference at the Chinese embassy in Khartoum on Wednesday.

‘The vaccines, developed and produced by the Sinopharm Group, are scheduled to arrive on 26 March on a Chinese aircraft to the Khartoum International Airport,’ the ambassador added.

الصين تمنح السودان "250" الف جرعة من لقاح سينوفارم المضاد لكورونا https://t.co/8mEl8PtRAQ
#سونا #السودان pic.twitter.com/T9UYdZIUVU

— SUDAN News Agency (SUNA) 🇸🇩 (@SUNA_AGENCY) March 24, 2021

Earlier this month, Sudan became the first country in the Middle East and North Africa region to receive vaccine doses through the COVAX facility when 828,000 doses of the shot produced by AstraZeneca arrived on 3 March 2021.

Sudan is a participant in the COVAX Facility and requested 17 million doses of COVID-19 vaccines to cover 8.5 million people, representing 20% of its population. Sudan is confirmed to receive 3.4 million doses of AstraZeneca vaccine. These doses will arrive in two shipments – the first which arrived on 3 March targets healthcare workers and people aged 45 and above with medical conditions and living in areas with high transmission or anticipated high transmission across the country. The remaining doses are expected in the second quarter of 2021. 

The first batch of vaccines were delivered with UNICEF’s support through COVAX, a coalition co-led by the World Health Organization (WHO), Gavi, the Global Vaccines Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), working on the equitable distribution of COVID-19 vaccines to countries regardless of their income.

There are now two vaccines that are available in Sudan: AstraZeneca and Sinopharm.

As of 21 March 2021, Sudan has reported over 29,599 infections, 23,926 recoveries and 2,016 deaths from the virus.

التقرير الوبائي ليوم الاحد الموافق 21 مارس 2021م.
عدد الحالات الجديدة ( 76 حالة ).
عدد التعافي الجديدة ( 68 حالة ).
عدد الوفيات الجديدة ( 13 وفاة ).#كورونا_الموجة_الثانية pic.twitter.com/hRoMwUT8x7

— وزارة الصـحة – السـودان (@FMOH_SUDAN) March 24, 2021

All you need to know about the Sinopharm COVID-19 vaccine:

Sinopharm’s China National Biotec Group (CNBG). Sinopharm is a Chinese state-owned biotech company based in Beijing. The shot is called BBIBP-CorV. the Sinopharm shot had been conducted in 10 countries worldwide. The vaccine has been granted authorisation in China, Pakistan, Egypt, Jordan, Bahrain, the UAE, Morocco, Hungary, Peru and the Philippines.

Related posts: